Topic: Health

Researchers at Indiana University School of Medicine discovered a potential new way to treat Alzheimer's disease by targeting an enzyme called IDOL. In lab studies, removing this enzyme from brain cells significantly reduced amyloid plaques and may help the brain resist damage linked to the disease.

Scientists have been searching for better treatments for Alzheimer's disease. Now, researchers at Indiana University School of Medicine have found a potential new way to treat the disease by targeting an enzyme called IDOL. In laboratory studies, removing this enzyme from brain cells significantly reduced amyloid plaques, one of the main biological hallmarks of Alzheimer's, and may help the brain resist damage linked to the disease.

The discovery comes as scientists continue searching for improved treatments for Alzheimer's. The U.S. Food and Drug Administration has already approved two disease-modifying drugs that work by clearing amyloid plaque buildup in the brain. These treatments can help stabilize patients by slowing further decline.

The Indiana University team believes targeting IDOL could offer a different strategy for fighting Alzheimer's while also improving communication between brain cells and supporting healthy lipid metabolism.

Brain Cell Experiments Reveal Surprising Results

Researchers created two separate animal models of Alzheimer's disease by deleting the IDOL gene in different brain cell types, including neurons and microglia. Scientists originally expected microglia to play a larger role in clearing amyloid plaques because these immune cells help remove harmful material from the brain and are the primary producers of IDOL. Instead, the most striking effects appeared when IDOL was removed from neurons.

Researchers found that deleting IDOL in neurons not only lowered plaque levels but also reduced levels of apolipoprotein E (APOE), a protein strongly associated with Alzheimer's disease. APOE is also important for regulating lipid metabolism in the brain.

Potential Benefits Beyond Plaque Removal

Researchers also found increased levels of receptors involved in regulating APOE and amyloid plaques after the enzyme was removed from neurons. These receptors are important for maintaining healthy communication between neurons and supporting lipid metabolism.

The research team is now exploring several approaches for developing drugs that target the IDOL enzyme.

Why It Matters

This discovery could lead to new treatments for Alzheimer's disease, which affects millions of people worldwide. As India's population ages, understanding this disease and finding effective treatments becomes increasingly important.

Key Facts

• Researchers at Indiana University School of Medicine discovered a potential new way to treat Alzheimer's disease by targeting an enzyme called IDOL.
• Removing IDOL from brain cells significantly reduced amyloid plaques and may help the brain resist damage linked to the disease.
• The discovery comes as scientists continue searching for improved treatments for Alzheimer's, which affects millions of people worldwide.

Key Terms

IDOL

An enzyme in the brain that is involved in Alzheimer's disease

Implications

This discovery could lead to new treatments for Alzheimer's disease, which affects millions of people worldwide. As India's population ages, understanding this disease and finding effective treatments becomes increasingly important.